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Summary  There  is  no  internationally  recognized  case-deﬁnition  for  travel-
associated  enteric  fever  in  non-endemic  countries.  This  study  describes  the  patterns
of  case  reporting  between  2007  and  2011  as  travel-associated  or  not  from  the  surveil-
lance  data  in  England,  Wales  and  Northern  Ireland  (EWNI),  before  and  after  a change
in  the  time  component  of  the  case-deﬁnition  in  January  2011.  It  examines  in  par-
ticular  the  role  of  a  time  frame  based  on  the  reported  typical  incubation  period
in  deﬁning  a  case  of  travel-associated  enteric  fever.  The  results  showed  no  sig-
niﬁcant  differences  in  the  distribution  of  cases  of  enteric  fever  in  regards  to  the
interval  between  the  onset  and  UK  arrival  in  2011  compared  to  2007—2010  (p  =  0.98
for  typhoid  and  paratyphoid  A);  the  distribution  for  paratyphoid  B  was  also  similar
in  both  time  periods.  During  2007—2010,  93%  (1730/1853)  of  all  of  the  cases  were
classiﬁed  as  travel-associated  compared  to  94%  (448/477)  in  2011.  This  difference
was  not  statistically  signiﬁcant.  Changing  the  time  component  of  the  deﬁnition  of
travel-associated  enteric  fever  did  not  make  a  signiﬁcant  difference  to  the  propor-
tion  of  travel-associated  cases  reported  by  investigators.  Our  analysis  suggests  that
time  might  be  subordinate  to  other  considerations  when  investigators  classify  a  case
as  travel-associated.
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rntroductionnteric  fevers  (otherwise  known  as  typhoid  and
aratyphoid  fevers,  which  in  this  study  are  referred
o as  ‘typhoid’  and  ‘paratyphoid’)  are  exclusively
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oute and  caused  by  Salmonella  enterica  sub-
pecies  enterica  serovar  Typhi  and  Paratyphi  A,  B,
nd C.  Unlike  other  Salmonella  spp.,  they  primar-
ly cause  a  systemic  illness  with  fever,  headache,
tomach pain,  loss  of  appetite  and  nausea;  diar-
hea might  be  present  in  some  cases,  but  not
ll. The  illness  varies  in  severity;  paratyphoid  has
een reported  in  the  literature  to  be  typically
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milder  than  typhoid,  although  more  recent  stud-
ies have  suggested  that  there  is  little  difference
between their  clinical  presentations  [1,2],  and  both
could be  serious  and  life-threatening  unless  treated
promptly  with  antibiotics.  The  incubation  periods
for enteric  fevers  are  dependent  on  the  infectious
dose and  the  vehicle  in  which  the  organisms  are
ingested  as  well  as  on  host  factors  [3,4]. Typical
ranges quoted  in  the  literature  are  8—14  days  and
10—20 days  for  typhoid  and  1—10  days  for  paraty-
phoid [5]  although  the  range  might  be  wider,  and
the extreme  range  for  typhoid  is  quoted  as  3—60
days [5,6].
Enteric fevers  occur  in  parts  of  the  world  where
hygiene and  sanitation  are  poor.  The  latest  esti-
mates for  the  number  of  typhoid  and  paratyphoid
cases occurring  globally  were  21.7  million  and
5.4 million,  respectively,  in  2000  [7].  The  regions
of high  incidence  are  Africa,  parts  of  South  and
South-East  Asia,  South  America  and  several  Asian
regions  of  the  former  USSR  [8]. Enteric  fever  in  the
United Kingdom  [2]  and  other  countries  in  west-
ern Europe  [9—12],  the  United  States  [13], Canada
[14],  Australia  [15], New  Zealand  [16],  Japan  [17]
and  Singapore  [18]  is  most  often  associated  with
travel to  or  arrival  from  an  endemic  country.  In
many published  studies  on  travel-associated  enteric
fever, ‘‘travel-associated’’  is  not  explicitly  deﬁned,
or where  it  is deﬁned,  the  time  interval  between
travel and  the  onset  of  symptoms  used  in  the  def-
inition  differs  across  countries,  with  the  maximum
varying between  three  weeks  and  three  months
(Table  1).
National  enhanced  surveillance  of  enteric  fever
in England,  Wales  and  Northern  Ireland  (EWNI)
began in  May  2006,  and  all  of  the  cases  in  which
Salmonella Typhi  or  Paratyphi  has  been  isolated
from a  blood  (optimally)  or  fecal  sample  are
eligible for  inclusion.  All  of  the  isolates  are  con-
ﬁrmed and  typed  by  the  Salmonella  Reference
Service at  Public  Health  England,  Colindale.  The
protocol  and  questionnaire  for  the  surveillance
were developed  by  a  multidisciplinary  collabora-
tive steering  group  drawn  from  laboratory  and
epidemiological specialists  and  practitioners  in
Public Health  England  (PHE)  (formerly  the  Health
Protection  Agency),  the  Local  Authorities  Coor-
dinators  of  Regulatory  Services  and  the  National
Travel Health  Network  and  Centre  (NaTHNaC).  The
questionnaires  are  completed  by  Local  Authority
environmental health  ofﬁcers  or  the  local  PHE
staff, depending  on  the  local  arrangements,  and
coordinated  nationally  by  the  Travel  and  Migrant
Health Section  (TMHS)  at  the  PHE  Centre  for
Infectious Disease  Surveillance  and  Control  in  Colin-
dale. Between  2007  and  2011,  questionnaires  were
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ubmitted  to  TMHS  for  86%  of  laboratory-conﬁrmed
ases.
Until  2011,  a travel-associated  case  of  enteric
ever was  deﬁned  in  the  national  surveillance  ques-
ionnaire  as  onset  within  three  weeks  of  arrival
n or  return  to  the  UK  from  abroad.  This  deﬁni-
ion was  based  on  the  typical  maximum  incubation
eriod quoted  for  typhoid  [25]  and  expert  con-
ensus from  the  steering  group.  For  simplicity,
he identical  deﬁnition  was  used  for  typhoid  and
aratyphoid  despite  their  reportedly  different  incu-
ation periods  because,  at  the  time  of  completion
f the  questionnaire,  the  causative  organism  might
ot be  known.  Analysis  of the  data  collected
etween 2007  and  2010  demonstrated  that  inves-
igators  did  not  always  adhere  to  the  three-week
ut off  period  for  deﬁning  a travel-associated  case
f enteric  fever,  particularly  in  cases  in  which  there
ad been  travel  to  a known  endemic  country  out-
ide the  deﬁned  time  frame.  The  vast  majority  of
ases between  2007  and  2010  had  an  onset  of illness
p to  one  month  after  arrival  in  or return  to  the  UK
rom abroad.  In  the  light  of  these  ﬁndings,  the  def-
nition of  a travel-associated  case  was  changed  in
anuary 2011  to  cases  that  had  an  onset  of  illness
ithin one  month  after  arrival  in  or  return  to  the
K from  abroad.  For  analysis  purposes,  a  month  was
eﬁned as  28  days.
This  study  retrospectively  describes  the  pat-
erns of  reporting  of  cases  as  travel-associated  or
ot, before  and  after  the  change  in  deﬁnition  of
 travel-associated  case,  to  examine  how  much
eight investigators  gave  to  the  time  frame  of  the
eﬁnition  and  to  consider  the  appropriateness  of
he change  in  deﬁnition.  The  general  epidemiology
f enteric  fevers  in  EWNI  is  beyond  the  scope  of  this
tudy  and  is  available  elsewhere  [2].
ethods
he  data  from  national  surveillance  are  managed
ith a  Microsoft  Access  2007  database  and  were
nalyzed  for  this  study  using  Microsoft  Excel  2007.
n cases  in  which  a  questionnaire  could  not  be  com-
leted, information  on  the  travel  history  might  be
btained  from  the  laboratory  request  form  (for  the
ountry of  travel  only)  or  directly  from  the  local  PHE
ealth Protection  Teams.  The  investigators  com-
leting questionnaires  are  asked  to  classify  a  case
s travel-associated  or  not  (based  on  the  deﬁnitions
s described  above)  and  to  complete  information
bout the  onset  date  of  illness  and  dates  of  any
ravel.  The  time  (in  days)  between  overseas  travel
nd the  onset  date  was  calculated  for  all  of  the
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Table  1  Deﬁnitions  of  travel-associated  enteric  fever  in  developed  countries.
Country  Deﬁnition  of  travel-associated
enteric  fever
Geographical
element
Incubation
period
included  in
deﬁnition
Time
element
Canada  [14] If  traveled  to  an  endemic  area
during  at  least  part  of  the
incubation  period  (21  days  for
typhoid,  10  days  for  paratyphoid)
or  had  traveled  to  a  non-endemic
area  outside  of  Canada  for  the
entire  incubation  period.
All countries  Yes  21  days
typhoid,  10
days
paratyphoid
Canada  [19]  For  a  travel-associated  case:  the
delay  between  the  departure  and
onset  must  be  greater  than  or
equal  to  the  minimum  incubation
period  (7  days)  and  the  delay
between  the  return  and  onset
dates  must  be  less  than  the
maximum  incubation  period  (21
days).
All  countries  Yes  Between  7
and  21  days
France  [10] Cases  occur  within  a  month  of
return  from  a  stay  abroad.
All countries No  1  month
Israel  [20]  Cases  of  enteric  fever  occurring
within  6  weeks  of  recent  travel.
All countries  No  6  weeks
Netherlands  [21]  Culture  conﬁrmed  or  serologically
conﬁrmed  acute  typhoid  fever
with  compatible  symptoms  in  a
person  who  has  been  in  a
developing  country  for  a  4-week
period  preceding  onset  of  illness.
Developing
country
No 4  weeks
Netherlands  [12]  First  day  of  illness  at  least  3  days
after  departure  and  within  1
month  of  return  from  (sub)
tropical  areas.
(Sub)  tropical
areas
No  Between  3
days  and  1
month
New  Zealand  [16]  Cases  that  report  overseas  travel
during  the  incubation  period
(8—14  days  typhoid;  1—10  days
paratyphoid  stated  in
Communicable  Diseases  Manual
[22]).
All  countries  Yes  1—3  weeks
Singapore  [23] Cases  were  classiﬁed  as  imported
if  there  was  a  history  of  travel  to
an  endemic  country  between  7
and  21  days  before  the  onset  of
symptoms.
Endemic  area  No  Between  7
and  21  days
Switzerland  [11]  Non-travel  cases  were  those  in
which  the  case  had  not  traveled
within  3  months  before  the  onset.
All  countries  No  3  months
USA  [24]  Traveled  outside  the  US  in  the  6
weeks  before  illness  onset.
All  countries  No  6  weeks
USA  [13]  Travel-associated  typhoid  fever  is
deﬁned  as  a  case  of  typhoid  fever
meeting  the  national  surveillance
case  deﬁnition  in  a  person  who
traveled  outside  of  the  United
States  in  the  30  days  before
illness.
All  countries  No  30  days
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symptomatic  cases  reported  through  the  enhanced
surveillance  scheme  between  2007  and  2011  inclu-
sive, where  both  dates  were  known.  For  the  purpose
of this  study,  the  time  between  overseas  travel  and
the onset  date  is deﬁned  from  the  date  of  return
to or  arrival  in  the  UK  and  includes  those  whose
trip originated  from  the  UK  and  those  who  were
new entrants  or  visitors  to  the  UK.  Cases  were
excluded from  the  analysis  if  they:  had  more  than
one organism  isolated  (at  the  species  level  only;  dif-
ferent phage  and  antibiotic  resistance  types  were
not considered  in  this  study),  had  no  onset  or  travel
dates,  had  onset  before  departure  from  the  UK,  or
had onset  before  the  minimum  quoted  incubation
period after  arrival  in  an  endemic  country  (one  day
for paratyphoid  and  three  days  for  typhoid).
Cases  reported  between  2007  and  2010  were
compared with  those  reported  in  2011  in  terms
of the  time  between  the  onset  date  and  over-
seas travel  and  the  correspondence  between
the investigator  classiﬁcation  and  the  operational
travel-associated  deﬁnition.  The  Mann—Whitney
U test  was  calculated  at  the  5%  level  (two-
tailed) using  IBM  SPSS  Statistics  Version  19  to
assess whether  there  were  any  differences  in  the
non-normally  distributed  time  intervals  between
the onset  date  and  the  dates  of  overseas  travel
between cases  of  typhoid  and  paratyphoid  A  dur-
ing 2007—2010  and  between  2007—2010  and  2011.
The two-independent  samples  z  test  at  the  95%
level was  calculated  using  STATA  (STATA/SE  12.0  for
Windows, Stata  Corp  LP.,  USA)  to  assess  the  signif-
icance  of  the  difference  between  the  proportions
of cases  classiﬁed  as  travel-associated  in  the  two
time periods.  It  is  assumed  that  all  of  the  investi-
gators administered  the  questionnaires  identically
and  that  all  of  the  cases  had  an  equal  chance  of
being interviewed  and  of  answering  all  of  the  ques-
tions.
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Table  2  Completeness  of  reporting  travel  and  onset  dates
Variables  
Total  symptomatic  cases  
Travel  history  of  symptomatic  cases  as  designated  by
investigator
Travel-associated  cases  designated  by  investigator  
Travel-associated  cases  designated  by  investigator:
With  travel  dates
With  onset  date  
With  both  travel  and  onset  dates
With  both  travel  and  onset  dates  and  excluding
cases  with  onset  before  travelJ.  Freedman  et  al.
esults
ompleteness of reporting
able  2  shows  the  completeness  of  reporting  for  the
nset and  travel  history  of  cases  during  2007—2010
nd 2011.  Reporting  was  much  improved  in  2011
ith 83.2%  of  travel-associated  cases,  as  designated
y the  investigators,  having  travel  dates  and  onset
ate, compared  to  65.2%  during  2007—2010.
ases reported between 2007 and 2010
etween  2007  and  2010,  1966  laboratory-conﬁrmed
ymptomatic  cases  of  typhoid  and  paratyphoid
 and  B  (single  isolates  only)  were  reported  in
WNI (an  average  of  492  each  year).  Of  the  cases
ith a complete  travel  history  (N  = 1845),  1725
93.5%)  were  classiﬁed  as  travel-associated  by  the
nvestigator,  and  123  (6.5%)  were  classiﬁed  as  non-
ravel-associated.  The  non-travel-associated  cases
omprised the  following:  37  speciﬁcally  stated  they
ad not  traveled  at  all;  24  had  traveled  to  an
ndemic country  but  the  onset  was  before  depar-
ure from  the  UK  or  occurred  more  than  21  days
fter overseas  travel;  and  for  the  remaining  62
ases, it  was  unknown  whether  there  had  been  no
ravel or  if  there  had  been  travel  outside  of  the
ncubation period.  This  information  was  not  specif-
cally requested  on  the  questionnaire.
Between  2007  and  2010,  after  the  exclusion
riteria were  applied,  a  total  of  1274  cases
f travel-associated  enteric  fever  (678  cases  of
yphoid,  549  cases  of  paratyphoid  A  and  47  cases
f paratyphoid  B)  were  included  for  analysis  of
ime intervals  between  overseas  travel  and  onset;
4% (297/1227)  of  typhoid  and  paratyphoid  A  cases
ecame ill  while  they  were  abroad  (Fig.  1).  The
ajority  of  the  remaining  cases  (460/511,  90.0%
 for  enteric  fever  cases:  2007—2011.
N  cases  (%  total)
2007—2010  2011
1966  481
1845  (93.5)  477  (99.2)
1725  (87.4)  448  (93.1)
1262  (64.2)  374  (77.8)
1324  (67.3)  408  (84.8)
1281  (65.2)  400  (83.2)
1274 (64.8) 394  (81.9)
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aigure  1  Time  (days)  between  onset  date  and  arrival  in  
esignated  as  travel-associated  (N  =  1274,  65%  of  the  tota
yphoid;  359/419,  85.7%  paratyphoid  A)  became  ill
ithin 21  days  after  overseas  travel  and  a  further
4 (25/511,  4.9%  typhoid  and  39/419,  9.3%  paraty-
hoid A)  became  ill  between  22  and  28  days  after
verseas travel,  with  a  median  of  eight  days  for
yphoid  and  nine  days  for  paratyphoid  A.  There
as no  statistically  signiﬁcant  difference  in  the
istribution  of  time  intervals  between  onset  and
verseas  travel  between  typhoid  and  paratyphoid  A
p =  0.12).  For  paratyphoid  B,  43%  (20/47)  of  cases
ecame  ill  while  they  were  abroad,  and  the  remain-
er (27/47,  57%)  became  ill  within  21  days  after
verseas  travel,  most  (19/27,  70%)  within  the  ﬁrst
even days  (median  four  days).
ases reported in 2011
n  2011,  481  laboratory-conﬁrmed  symptomatic
ases of  typhoid  and  paratyphoid  A  and  B  (sin-
le isolates  only)  were  reported  in  EWNI.  Of
ases with  a  completed  travel  history  (477),  448
93.9%) were  designated  as  travel-associated  by  the
nvestigator,  and  29  (6.1%)  were  designated  as  non-
ravel-associated.  The  non-travel-associated  cases
omprised  the  following:  nine  cases  speciﬁcally
tated they  had  not  traveled  at  all;  one  had  trav-
led to  an  endemic  country,  though  not  recently
no dates  were  given);  for  the  remaining  19  cases,
t was  unknown  whether  there  had  been  no  travel,
r if  there  had  been  travel  outside  of  the  incubation
eriod. When  the  exclusion  criteria  were  applied,  a
otal of  394  travel-associated  cases  of  enteric  fever
T
t
a
aK  by  organism  with  cumulative  proportions  for  the  cases
ses):  2007—2010.
203  cases  of  typhoid,  184  cases  of  paratyphoid  A
nd seven  cases  of  paratyphoid  B)  were  included
or analysis  of  time  between  onset  and  overseas
ravel; 21%  (80/387)  of  the  typhoid  and  paraty-
hoid A  cases  became  ill  while  they  were  abroad,
hereas 43%  (3/7)  of  the  paratyphoid  B  cases
ecame ill  while  they  were  abroad  (Fig.  2).  The
ajority  of  the  remaining  cases  (151/159  typhoid
5%; 141/148  paratyphoid  A  95%;  3/7  paratyphoid
 43%)  became  ill  within  28  days  of  overseas  travel,
ith  a  median  of  seven  days  for  typhoid  and  nine
ays for  paratyphoid  A.  There  was  no  statistically
igniﬁcant difference  in  the  distribution  of the
ime intervals  between  onset  and  overseas  travel
etween  typhoid  and  paratyphoid  A  (p  = 0.41).
There were  no  signiﬁcant  differences  in  the  dis-
ribution  of  cases  of  typhoid  and  paratyphoid  A  in
egards to  the  interval  between  onset  and  over-
eas travel  in  2011  compared  to  2007—2010  (p = 0.98
or typhoid  and  paratyphoid  A);  the  distribution  for
aratyphoid B  was  similar  in  2011,  except  for  one
ase of  paratyphoid  B  with  onset  of  symptoms  56
ays after  return  to  the  UK  (Fig.  2).
lassiﬁcation of travel-associated and
on-travel-associated cases before and
fter the change in deﬁnitionhere  was  no  signiﬁcant  difference  in  the  propor-
ion of  total  cases  classiﬁed  as  travel-associated
nd non-travel-associated  after  the  deﬁnition  of
 travel-associated  case  changed  from  those  with
382  J.  Freedman  et  al.
l  in  
al  ca
D
T
w
i
a
t
s
a
i
c
h
e
f
t
tFigure  2  Time  (days)  between  the  onset  date  and  arriva
cases  designated  as  travel-associated  (N  =  394,  82%  of  tot
onset  within  28  days  compared  to  those  within  21
days of  overseas  travel  (Table  3).
If the  case  deﬁnitions  in  use  for  each  time  period
had been  strictly  applied  to  designate  the  travel
status of  the  case,  then  the  number  of  poten-
tially misclassiﬁed  UK  acquired  cases  would  have
increased  by  111  (90.2%)  in  2007—2010  and  by  16
(55.2%)  in  2011.  It  is  unclear  from  the  information
given on  the  surveillance  forms  whether  further
investigations were  undertaken  to  seek  a  potential
UK source  in  the  cases  that  did  not  strictly  ﬁt  the
case deﬁnition;  however,  all  but  two  of  these  cases
were  known  to  have  recently  arrived  from  or  had
traveled  to  a  known  endemic  country,  most  on  the
Indian subcontinent.  One  case  classiﬁed  as  travel-
associated  outside  the  case  deﬁnition  in  2008  had
traveled  to  Germany,  a  country  not  typically  known
to be  endemic  for  enteric  fever  as  classiﬁed  by
NaTHNaC,  and  one  case  in  2007  had  no  country  of
travel stated.
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Table  3  Designation  of  enteric  fever  as  travel-associated
deﬁnition  of  a  travel-associated  case:  2007—2011.
Designation  of  cases  by  investigator  2007—2010  
Travel-associated  cases  (%  of  total) 1725  (93.5)
(95%  CI:
92.4—94.6)
Non  travel-associated  cases  (%  of  total)  123  (6.5)
(95%  CI:
5.4—7.6)
Total  with  known  travel  history  1845  the  UK  by  organism  with  cumulative  proportions  for  the
ses):  2011.
iscussion
here  are  a number  of  challenges  associated
ith surveillance  of  travel-associated  infections
n developed  countries  [26],  in  particular  the
scertainment of  complete  travel  and  clinical  his-
ories and  the  absence  of  an  international  ‘gold
tandard’  case-deﬁnition  for  travel-  and  non-travel-
ssociated  cases.  Enhanced  surveillance  has  greatly
mproved  the  completeness  and  quality  of  the  data
ollection  on  enteric  fever  in  these  respects  and
as enabled  a more  accurate  assessment  of  the
nteric fever  situation  in  EWNI  [2]. Although  enteric
ever is  primarily  a  travel-associated  infection  in
he UK,  sporadic  cases  associated  with  secondary
ransmission from  a travel-associated  case  [28]  and
mall clusters  that  are  presumed  to  have  been
cquired in  the  UK  have  infrequently  occurred
29—31]. More  rigorous  and  time-consuming  inves-
igation and  public  health  action  is required  for
 or  not  by  investigators,  pre  and  post  the  change  in
2011  %  Change  between
2007—2010  and  2011
448  (93.9)
(95%  CI:
91.8—96.0)
Increased  by  0.4%  —  not
signiﬁcant  (p  =  0.75)
29  (6.1)
(95%  CI:
4.0—8.2)
Decreased  by  0.4%  —  not
signiﬁcant  (p  =  0.75)
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aravel-associated  cases  of  enteric  fever  
on-travel-associated  cases;  therefore,  it  is  impor-
ant that  cases  be  classiﬁed  appropriately.
One means  of  appropriate  classiﬁcation  has  been
n the  basis  of  a  temporal  relationship  between
ymptom onset  and  travel.  The  initial  deﬁnition  of
 travel-associated  case  as  symptom  onset  within  a
hree-week (21  day)  period  of  overseas  travel  was
ot always  adhered  to  by  investigators.  Differing
ncubation periods  stated  in  various  UK  guide-
ines for  investigating  enteric  fever  in  use  at  the
ime [25,32]  might  partly  account  for  the  differ-
ng assessments,  but  not  strictly  adhering  to  the
nitial deﬁnition  might  also  reﬂect  the  fact  that
time since  travel’  is  only  one  factor  that  inves-
igators consider  in  assessing  cases  (for  example,
% of  cases  in  2007—2010  and  2011  were  desig-
ated as  travel-associated  when  they  had  onset
fter 28  days  from  overseas  travel).  Although  there
re a  number  of  other  questions  included  in  the
urveillance  questionnaire  [2]  to  ascertain  whether
 case  might  have  been  acquired  in  the  UK,  the
eason for  the  designation  as  travel-associated  or
ot is  not  always  clear.  This  study  shows  that
hanging the  deﬁnition  of  travel-associated  cases
f enteric  fever  in  terms  of  the  time  between  symp-
om onset  and  overseas  travel  did  not  signiﬁcantly
ffect the  proportion  of  cases  designated  by  inves-
igators  as  travel-associated.  Our  analysis  suggests
hat time  might  be  subordinate  to  other  consid-
rations when  investigators  classify  a  case,  if,  for
xample,  there  is  no  other  plausible  source  of  infec-
ion for  the  individual  other  than  likely  exposure
broad, especially  in  cases  in  which  travel  to  an
ndemic  country  is  known.  This  ﬁnding  is  consis-
ent with  a  Norwegian  study  that  considered  the
nﬂuence  of  time  between  return  to  Norway  and
ymptom onset  for  other  gastrointestinal  (GI)  infec-
ions; the  study  concluded  that  clinicians  are  likely
o take  into  account  the  usual  epidemiology  of  the
nfection  within  the  home  country  when  assessing
hether a  GI  infection  is  travel-associated  even  if
here is  a  long  period  between  return  to  the  home
ountry and  symptom  onset  [33].  A  high  propor-
ion of  typhoid  and  paratyphoid  fever  cases  in  EWNI
ave traveled  abroad  to  visit  friends  and  relatives
27],  and  many  travel  together  in  family  groups;
herefore, it  is  possible  that  secondary  cases  within
 traveling  group  might  be  mistaken  for  primary
ravel-associated  cases,  which  may  account  for  the
onger apparent  incubation  period  in  some  cases.
The purpose  of  a  time  frame  is  to  provide  guid-
nce to  investigators  on  which  cases  are  very  likely
o be  travel-associated  and  to  help  identify  the
ases in  which  further  consideration  should  be
iven  to  the  likelihood  of  them  being  UK-acquired
i.e., to  prompt  the  investigation  of  other  possible
m
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isk  factors),  which  is  of  signiﬁcance  because  UK
cquired  cases  require  higher  levels  of  public  health
ction. One  of  the  concerns  that  might  be  raised
bout extending  the  time  frame  for  deﬁning  a case
s travel-associated  is  that  non-travel-associated
ases might  be  consequently  misclassiﬁed  and  not
ppropriately  investigated  and  managed,  leading  to
lusters of  indigenous  disease.  There  is no  evidence
rom the  enhanced  surveillance  that  the  change
n deﬁnition  has  led  to  more  UK-acquired  cases  of
nteric fever  being  misclassiﬁed  in  2011  than  in
revious years.
The  limitations  of  this  study  predominantly
elate to  the  completeness  of  data  capture,
lthough this  aspect  has  improved  over  time.  In
articular,  for  most  cases  classiﬁed  as  non-travel-
ssociated, the  basis  on  which  this  classiﬁcation
as made  was  not  clear  (e.g.,  because  of  the  tem-
oral relationship  between  travel  and  symptoms  or
ecause there  had  been  no  travel);  this  information
s not  requested  on  the  form,  but  it  might  be  worth
evising  the  questionnaire  to  include  this  informa-
ion for  a future  audit.  Limited  information  was
rovided  on  the  surveillance  form  about  possible
ources for  non-travel-associated  infections.  Some
ources are  likely  to  be  as  a result  of  contact  with
nown  cases  within  a  household;  between  2007  and
011, 14%  (22/152)  of  non-travel-associated  cases
ere likely  to  have  been  infected  from  a  household
ontact who  might  or  might  not  have  traveled  them-
elves. Subsequent  to  this  study,  and  in  part  based
n its  ﬁndings,  new  ‘Public  Health  Operational
uidelines for  Enteric  Fever  (Typhoid  and  Paraty-
hoid)’ [34]  were  published  in  early  2012.  These
uidelines aim  to  improve  the  investigation  of  non-
ravel-associated  cases,  providing  algorithms  for
nvestigators  to  use  in  trying  to  identify  potential
ources of  infection  in  the  absence  of  a  travel  his-
ory within  28  days  of  the  onset  of  symptoms.  Part
f the  evaluation  of  these  guidelines  [35]  includes
 detailed  analysis  of  cases  known  or  suspected  to
e acquired  in  the  UK  to  assess  the  value  of  more
horough  investigation  of  cases  with  a long  period  of
ime between  overseas  travel  and  the  onset  date.
t is anticipated  that  data  completeness  will  be
uch improved  subsequent  to  the  implementation
f these  guidelines.
For those  deciding  the  public  health  actions
equired in  response  to  a case  of  enteric  fever,  the
emporal  deﬁnition  provides  useful  guidance  (in
onjunction  with  other  information  about  the  case)
s to  what  public  health  actions  are  required.  It
ight be  that  once  the  investigation  of  the  case
s complete  and  also  considering  the  possibility  of
ny contact  with  co-travelers,  travel  abroad  is the
ost likely  source  in  the  absence  of  evidence  to  the
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contrary,  even  if  the  case  had  onset  of  symptoms
more than  28  days  after  arrival  in  or  return  to  the
UK. For  surveillance  reporting  and  data  analysis
purposes, it  is  appropriate  to  continue  to  rely  on
the professional  judgment  of  the  public  health
practitioner to  deﬁne  a  case  as  travel-associated
(or presumed  travel-associated)  as  is  currently  the
case [2,28].
In  this  analysis,  the  vast  majority  of  enteric
fever cases  reported  in  EWNI  between  2007  and
2011, in  which  the  individuals  did  not  become  ill
while  they  were  abroad,  had  onset  dates  within
28 days  of  arrival  in  or  return  to  the  UK,  with  a
median  of  nine  days  and  seven  days  for  paraty-
phoid A  and  typhoid,  respectively,  and  a  median  of
ﬁve days  for  paratyphoid  B.  The  data  demonstrate
that, although  the  median  for  typhoid  was  slightly
lower, there  was  no  signiﬁcant  difference  between
typhoid and  paratyphoid  A  in  this  respect,  suggest-
ing similar  incubation  periods  for  these  organisms;
however, the  data  suggest  that  paratyphoid  B  has  a
shorter typical  incubation  period.  The  upper  limit
of the  typical  incubation  period  quoted  in  the  liter-
ature  for  enteric  fevers  is  lower  than  that  observed
in this  case  series.  This  difference  is  especially
striking because  this  analysis  measures  time  from
arrival  in  the  UK  to  onset  as  a  proxy  for  the  incu-
bation period,  rather  than  the  time  from  infection
to onset,  so  that  the  actual  maximum  incubation
periods observed  in  this  study  are  likely  to  be
longer. For  enteric  fever,  as  well  as  many  other
infections, incubation  periods  vary  between  indi-
viduals,  depending  on  the  infecting  dose  and  the
immune  status  and  general  health  of  the  individual
who has  been  infected.  Using  the  duration  between
travel and  symptom  onset  is  only  one  factor  to
consider  in  determining  whether  or  not  a  case  is
travel-associated.
Conclusion
Epidemiology  is  a  complex  science,  and  although
evidence-based  guidelines  for  best  practice  are
useful in  investigating  cases  of  infectious  disease,
public  health  professionals  must  use  their  profes-
sional judgment  when  a  case  does  not  appear  to
be consistent  with  the  rules.  The  key  is to  be  able
to gather  as  much  information  as  possible  about
the case  for  accurate  and  consistent  reporting  and
analysis  of  the  data.  Surveillance  will  continue  to
provide  evidence  to  inform  and  improve  the  pub-
lic health  management  of  cases  and  to  improve  the
advice given  to  travelers  who  might  be  at  increased
risk of  acquiring  enteric  fever  through  overseas
travel.J.  Freedman  et  al.
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